Naval Medical Logistics Command, Code 05, 521 Fraim Street, Ft. Detrick, MD 21702-5015

65 -- LSD METABOLITE, 2-OXO, 3-HYDROXY-LSD IMMUNOASSAY REAGENT POC Ralph Payne, 301/619-3026 E-MAIL: Naval Medical Logistics Command, rpayne@nml10.med.navy.mil. The Naval Medical Logistics Command has a requirement to identify potential sources to provide immunoassay test reagent specific for the lysergic acid diethylamide (LSD) metabolite, 2-oxo, 3-hydroxy-LSD. The reagent shall be for the initial (screen) testing for the LSD metabolite 2-oxo, 3-hydroxy-LSD in urine from LSD abuse. The reagent must provide performance characteristics of sensitivity and specificity for detection of the LSD metabolite 2-oxo, 3-hydroxy-LSD in urine at 1.0 ng/ml or less. The reagent must be compatible for use with the Olympus AU800 automated drug screening equipment, and must be applicable without modification of the equipment. The reagent must be compatible with the optimal throughput of the AU800 and must not interfere with the optimum performance of other immunoassay procedures in the military laboratories. Be advised that this is not a request for the submission of offers or proposals; no contract award will be made as a result of this notice. Responses shall include relativeinformation to provide the LSD metabolite, 2-oxo, 3-hydroxy-LSD reagent sought. Immunoassay kits are medical devices which require FDA approval to market. Responses shall indicate FDA compliance or the estimated lead time required to obtain FDA approval. Responses to this sources sought notice shall be submitted no later than 30 days after the date of this notice, to Naval Medical Logistics Command, ATTN: Ralph Payne, 521 Fraim Street, Fort Detrick, MD 21702-5015. Responses may also be faxed to 301-619-2925 or emailed to rpayne@nml10.med.navy.mil. Posted 05/20/99 (W-SN333708). (0140)

Loren Data Corp. http://www.ld.com (SYN# 0321 19990524\65-0007.SOL)